Published in J Am Acad Dermatol on January 01, 1994
Intragenic copy number variation within filaggrin contributes to the risk of atopic dermatitis with a dose-dependent effect. J Invest Dermatol (2011) 1.97
Prevalence of asthma, rhinitis and eczema among children in 2 Canadian cities: the International Study of Asthma and Allergies in Childhood. CMAJ (1999) 1.84
The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. Allergy Asthma Immunol Res (2011) 1.69
Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol (2013) 1.57
Retracted Pimecrolimus cream 1% in the management of atopic dermatitis in pediatric patients: a meta-analysis. PLoS One (2014) 1.41
Clinical evidence: atopic eczema. BMJ (1999) 1.34
Variants in a novel epidermal collagen gene (COL29A1) are associated with atopic dermatitis. PLoS Biol (2007) 1.21
The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma. J Clin Cell Immunol (2014) 1.06
Epidermal barrier in atopic dermatitis. Allergy Asthma Immunol Res (2011) 1.04
Thymic stromal lymphopoietin (TSLP)-mediated dermal inflammation aggravates experimental asthma. Mucosal Immunol (2012) 1.02
Itch, sneeze and wheeze: the genetics of atopic allergy. J R Soc Med (2002) 1.01
Atopy in children and parental social class. Am J Public Health (1998) 1.00
A proposal: Atopic Dermatitis Organizer (ADO) guideline for children. Asia Pac Allergy (2011) 0.96
Natural history and risk factors of atopic dermatitis in children. Allergy Asthma Immunol Res (2014) 0.93
Effects of prenatal and perinatal exposure to fine air pollutants and maternal fish consumption on the occurrence of infantile eczema. Int Arch Allergy Immunol (2011) 0.90
The short stature in atopic dermatitis patients: are atopic children really small for their age? Ann Dermatol (2013) 0.85
Influences of Environmental Chemicals on Atopic Dermatitis. Toxicol Res (2015) 0.82
A safety assessment of topical calcineurin inhibitors in the treatment of atopic dermatitis. MedGenMed (2006) 0.81
Eczema, sleep, and behavior in children. J Clin Sleep Med (2010) 0.81
Skin barrier function and its importance at the start of the atopic march. J Allergy (Cairo) (2012) 0.80
Improvement of atopic dermatitis severity after reducing indoor air pollutants. Ann Dermatol (2013) 0.79
Epidermal tight junctions in health and disease. Tissue Barriers (2015) 0.78
Effect of prenatal exposure to fine particulate matter and intake of Paracetamol (Acetaminophen) in pregnancy on eczema occurrence in early childhood. Sci Total Environ (2011) 0.78
Environmental risk factors and their role in the management of atopic dermatitis. Expert Rev Clin Immunol (2016) 0.75
Eczema. BMJ Clin Evid (2011) 0.75
Tacrolimus ointment in the management of atopic dermatitis. Clin Cosmet Investig Dermatol (2009) 0.75
Economic evidence for the prevention and treatment of atopic eczema: a protocol for a systematic review. Syst Rev (2016) 0.75
Daily application of fluocinonide 0.1% cream for the treatment of atopic dermatitis. J Clin Aesthet Dermatol (2009) 0.75
Therapeutic Effects of Fermented Flax Seed Oil on NC/Nga Mice with Atopic Dermatitis-Like Skin Lesions. Evid Based Complement Alternat Med (2017) 0.75
Epidemiology of headache and childhood migraine in an urban general practice using Ad Hoc, Vahlquist and IHS criteria. Dev Med Child Neurol (1992) 1.94
Nickel allergy following European Union regulation in Denmark, Germany, Italy and the U.K. Br J Dermatol (2013) 1.53
The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol (1994) 1.45
Delayed and immediate orofacial reactions following contact with rubber gloves during dental treatment. Br Dent J (1996) 1.39
Lichen planus is not commonly a skin marker of primary biliary cirrhosis. Dermatologica (1990) 1.37
The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol (1999) 1.34
Dermatitis herpetiformis: diagnosis, diet and demography. Gut (1984) 1.28
Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol (2012) 1.24
Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2). Clin Exp Immunol (1997) 1.17
Future research into the treatment of vitiligo: where should our priorities lie? Results of the vitiligo priority setting partnership. Br J Dermatol (2011) 1.10
Occupational contact dermatitis has an appreciable impact on quality of life. Contact Dermatitis (2001) 1.10
Chinese herbs for eczema, the active compound? Lancet (1991) 1.10
How safe is patch testing to PPD? Br J Dermatol (2006) 1.08
Clinical epidemiology of childhood abdominal migraine in an urban general practice. Dev Med Child Neurol (1993) 1.08
Early cellular reactions induced by dinitrochlorobenzene in sensitized human skin. Br J Dermatol (1984) 1.06
Rosacea: a study of clinical patterns, blood flow, and the role of Demodex folliculorum. J Am Acad Dermatol (1992) 1.03
Phenotypic characterization of the early cellular responses in allergic and irritant contact dermatitis. Clin Exp Immunol (1986) 1.02
The prevalence of headache and migraine in atopic children: an epidemiological study in general practice. Headache (1993) 1.01
The autoimmune regulator gene (AIRE) is strongly associated with vitiligo. Br J Dermatol (2008) 0.99
Identification of epitopes on tyrosinase which are recognized by autoantibodies from patients with vitiligo. J Invest Dermatol (1999) 0.96
White sponge naevus successfully treated with topical tetracycline. Clin Exp Dermatol (1990) 0.96
The discrimination between nickel-sensitive and non-nickel-sensitive subjects by an in vitro lymphocyte transformation test. Br J Dermatol (1990) 0.94
Detection of tyrosinase autoantibodies in patients with vitiligo using 35S-labeled recombinant human tyrosinase in a radioimmunoassay. J Invest Dermatol (1997) 0.93
Analysis of a microsatellite polymorphism of the cytotoxic T-lymphocyte antigen-4 gene in patients with vitiligo. Br J Dermatol (1999) 0.93
A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo. Genes Immun (2005) 0.93
Clearance of acanthosis nigricans associated with the HAIR-AN syndrome after partial pancreatectomy: an 11-year follow-up. Postgrad Med J (1999) 0.91
Bullous lichen planus and lichen planus pemphigoides--clinico-pathological comparisons. Clin Exp Dermatol (1989) 0.91
Notch4, a non-HLA gene in the MHC is strongly associated with the most severe form of alopecia areata. Hum Genet (2003) 0.91
Vitiligo presentation in adults. Clin Exp Dermatol (2005) 0.91
Azathioprine in dermatology: a survey of current practice in the U.K. Br J Dermatol (1997) 0.90
Do both paternal and maternal smoking influence the prevalence of childhood asthma? A study into the prevalence of asthma in children and the effects of parental smoking. J Asthma (1995) 0.89
A prospective study of the responsiveness of depression and suicidal ideation in acne patients to different phases of isotretinoin therapy. Eur J Dermatol (2005) 0.89
Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay. Br J Dermatol (1998) 0.89
Neuropeptide and neuronal marker studies in vitiligo. Br J Dermatol (1994) 0.88
Occupational skin disease in hospital cleaning and kitchen workers. Contact Dermatitis (1986) 0.88
Nickel sensitivity: the influence of ear piercing and atopy. Br J Dermatol (1992) 0.87
Role of the autoimmune regulator (AIRE) gene in alopecia areata: strong association of a potentially functional AIRE polymorphism with alopecia universalis. Tissue Antigens (2002) 0.87
Autoantibodies to human melanocyte-specific protein pmel17 in the sera of vitiligo patients: a sensitive and quantitative radioimmunoassay (RIA). Clin Exp Immunol (1998) 0.87
Patch testing in children and adolescents: five years' experience and follow-up. J Am Acad Dermatol (1997) 0.87
Food allergy in patients with eczema: immediate symptoms are usual, with nuts and tomatoes the major allergens. J Eur Acad Dermatol Venereol (2010) 0.86
Nickel as an occupational allergen. A survey of 368 nickel-sensitive subjects. Arch Dermatol (1998) 0.86
Vitiligo linked to stigmatization in British South Asian women: a qualitative study of the experiences of living with vitiligo. Br J Dermatol (2010) 0.86
The use of tinted glasses in childhood migraine. Headache (1991) 0.85
Nodular prurigo: metabolic diseases are a common association. Clin Exp Dermatol (2006) 0.85
Keratinocytes suppress TRP-1 expression and reduce cell number of co-cultured melanocytes - implications for grafting of patients with vitiligo. Pigment Cell Res (2001) 0.85
Consensus statement on the management of chronic hand eczema. Clin Exp Dermatol (2009) 0.85
Clinical, histological and immunological studies in 50 patients with bullous pemphigoid. Dermatologica (1988) 0.84
Type-IV hypersensitivity to betamethasone valerate and clobetasol propionate: results of a multicentre study. Br J Dermatol (2002) 0.84
Marfan's syndrome presenting as bilateral spontaneous pneumothorax. Postgrad Med J (1981) 0.84
Keratinocyte expression of MHC class II antigens in allergic sensitization and challenge reactions and in irritant contact dermatitis. J Invest Dermatol (1987) 0.84
Rifampicin allergy confirmed by an intradermal test, but with a negative patch test. Contact Dermatitis (2001) 0.83
A diagnostic test for migraine using the visual evoked potential. Headache (1988) 0.83
Physical friction is under-recognized as an irritant that can cause or contribute to contact dermatitis. Br J Dermatol (2006) 0.83
Growth hormone levels in psoriasis. Arch Dermatol Res (1984) 0.83
Oral lichenoid lesions and contact allergy to dental mercury and gold. Contact Dermatitis (2003) 0.83
Neuropeptides and general neuronal marker in psoriasis--an immunohistochemical study. Clin Exp Dermatol (1995) 0.82
Allergic contact dermatitis from natural rubber latex without immediate hypersensitivity. Contact Dermatitis (1999) 0.82
Werner's syndrome. Biochemical and cytogenetic studies. Arch Dermatol (1985) 0.82
1044 women with migraine: the effect of environmental stimuli. Headache (1994) 0.81
Sweet's syndrome in Crohn's disease. BMJ (1988) 0.81
Chromium- and nickel-induced cytotoxicity in normal and transformed human keratinocytes: an investigation of pharmacological approaches to the prevention of Cr(VI)-induced cytotoxicity. Br J Dermatol (1996) 0.81
The British standard series of contact dermatitis allergens: validation in clinical practice and value for clinical governance. Br J Dermatol (2003) 0.81
Contact allergy in patients with oral symptoms: a study of 47 patients. Am J Contact Dermat (1996) 0.81
Occupational dermatitis related to chromium and cobalt: experience of dermatologists (EPIDERM) and occupational physicians (OPRA) in the U.K. over an 11-year period (1993-2004). Br J Dermatol (2007) 0.81
Pseudocatalase and narrowband ultraviolet B for vitiligo: clearing the picture. Br J Dermatol (2009) 0.80
Molecular mapping of epitopes on melanocyte-specific protein Pmel17 which are recognized by autoantibodies in patients with vitiligo. Clin Exp Immunol (2001) 0.80
Contact sensitivity in pruritus vulvae: patch test results and clinical outcome. Am J Contact Dermat (1997) 0.80
MHC class II antigen expression in normal human epidermis. Immunology (1986) 0.80
The influence of extracellular matrix proteins on cutaneous and uveal melanocytes. Pigment Cell Res (1997) 0.80
alpha-Melanocyte stimulating hormone inhibits tumour necrosis factor-alpha stimulated intercellular adhesion molecule-1 expression in normal cutaneous human melanocytes and in melanoma cell lines. Br J Dermatol (1998) 0.80
Chromate: still an important occupational allergen for men in the UK. Contact Dermatitis (2003) 0.80
Treatment of psoriasis: day care vs. inpatient therapy. Br J Dermatol (1999) 0.79
Alpha-melanocyte stimulating hormone can reduce T-cell interaction with melanoma cells in vitro. Melanoma Res (2000) 0.79
Vitiligo melanocytes in long-term culture show normal constitutive and cytokine-induced expression of intercellular adhesion molecule-1 and major histocompatibility complex class I and class II molecules. Br J Dermatol (1998) 0.79
Glucose and diet in the fasting migraineur. Headache (1986) 0.78
alpha-MSH and melanogenesis in normal human adult melanocytes. Pigment Cell Res (1998) 0.78
Colophony: an unusual factor in pruritus vulvae. Contact Dermatitis (1994) 0.78
Type IV hypersensitivity reactions to natural rubber latex: results of a multicentre study. Br J Dermatol (2002) 0.78
Cytokine dermatosis: reactivation of eczema during interleukin-2 infusion. Br J Dermatol (1997) 0.77
Neonatal lupus erythematosus in four successive siblings born to a mother with discoid lupus erythematosus. Br J Dermatol (1984) 0.77
Dermatological causes of pruritus ani. BMJ (1992) 0.77
Photopatch testing of 1155 patients: results of the U.K. multicentre photopatch study group. Br J Dermatol (2006) 0.77
Contact allergy to testosterone in an androgen patch: control of symptoms by pre-application of topical corticosteroid. Contact Dermatitis (2001) 0.77
Hamartomatous congenital melanocytic nevi showing secondary anetoderma-like changes. J Am Acad Dermatol (1998) 0.77
Epitopes, avidity and IgG subclasses of tyrosine hydroxylase autoantibodies in vitiligo and alopecia areata patients. Br J Dermatol (2012) 0.77
The angiotensin-converting enzyme gene insertion/deletion polymorphism in Indian patients with vitiligo: a case-control study and meta-analysis. Br J Dermatol (2013) 0.77
Contact dermatitis from soybean extract in a cosmetic cream. Contact Dermatitis (2001) 0.77
Prognosis of occupational hand dermatitis in metalworkers. Contact Dermatitis (1996) 0.77
Investigation of the influence of extracellular matrix proteins on normal human melanocyte morphology and melanogenic activity. Br J Dermatol (1996) 0.77
Severe erythrodermic reactions to the proton pump inhibitors omeprazole and lansoprazole. Br J Dermatol (1999) 0.77
Facial dermatitis and eyelid dermatitis: a comparison of patch test results and final diagnoses. Contact Dermatitis (1996) 0.77
Dermal nickel exposure associated with coin handling and in various occupational settings: assessment using a newly developed finger immersion method. Br J Dermatol (2006) 0.76
Nickel dermatitis: the reaction to oral nickel challenge. Br J Dermatol (1986) 0.76
Phytophotodermatitis due to common rue (Ruta graveolens). Contact Dermatitis (1983) 0.76
The national survey of adverse reactions to dental materials in the UK: a preliminary study by the UK Adverse Reactions Reporting Project. Br Dent J (2004) 0.76
Occupational contact dermatitis in nurses with hand eczema. Contact Dermatitis (2001) 0.76
Melanocyte antigen-specific antibodies cannot be used as markers for recent disease activity in patients with vitiligo. J Eur Acad Dermatol Venereol (2012) 0.76
Morphologic observations on the dermal nerves in vitiligo: an ultrastructural study. Int J Dermatol (1995) 0.76
Contact sensitivity in pruritus vulvae: a common and manageable problem. Contact Dermatitis (1994) 0.76